COMBINATION THERAPY BASED ON BORTEZOMIB FOR PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA

被引：0
|
作者：
Cai, C. [1 ]
He, J. [1 ]
Yang, Y. [1 ]
Han, H. [1 ]
Zheng, G. [1 ]
Zheng, W. [1 ]
Wei, W. [1 ]
Wu, W. [1 ]
Ye, Y. [1 ]
Shi, S. [1 ]
Xie, X. [1 ]
Li, L. [1 ]
Zhang, Z. [1 ]
Huang, H. [1 ]
Huang, H. [1 ]
Zhen, Z. [1 ]
机构：
[1] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Hangzhou, Zhejiang, Peoples R China
来源：
HAEMATOLOGICA | 2012年 / 97卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1542
引用
收藏
页码：611 / 611
页数：1
相关论文
共 50 条
  • [1] Combination Therapy Based on Bortezomib for Newly Diagnosed Multiple Myeloma Patients
    He, Jingsong
    Yang, Li
    Jin, Dian
    Lin, Xuanru
    Yang, Qianqian
    Han, Xiaoyan
    Zheng, Gaofeng
    Zheng, Weiyan
    Wei, Guoqing
    Wu, Wenjun
    Ye, Xiujin
    Shi, Jimin
    Xie, Wanzhuo
    Zhang, Jie
    Lin, Maofang
    Huang, He
    Cai, Zhen
    [J]. BLOOD, 2012, 120 (21)
  • [2] Lenalidomide, bortezomib, and dexamethasone combination therapy in patients with newly diagnosed multiple myeloma
    Richardson, Paul G.
    Weller, Edie
    Lonial, Sagar
    Jakubowiak, Andrzej J.
    Jagannath, Sundar
    Raje, Noopur S.
    Avigan, David E.
    Xie, Wanling
    Ghobrial, Irene M.
    Schlossman, Robert L.
    Mazumder, Amitabha
    Munshi, Nikhil C.
    Vesole, David H.
    Joyce, Robin
    Kaufman, Jonathan L.
    Doss, Deborah
    Warren, Diane L.
    Lunde, Laura E.
    Kaster, Sarah
    DeLaney, Carol
    Hideshima, Teru
    Mitsiades, Constantine S.
    Knight, Robert
    Esseltine, Dixie-Lee
    Anderson, Kenneth C.
    [J]. BLOOD, 2010, 116 (05) : 679 - 686
  • [3] The Choice Of Regimens Based On Bortezomib For Patients With Newly Diagnosed Multiple Myeloma
    Yang, Li
    He, Jingsong
    Han, Xiaoyan
    Zheng, Gaofeng
    Zheng, Weiyan
    Wei, Guoqing
    Wu, Wenjun
    Ye, Xiujin
    Shi, Jimin
    Xie, Wanzhuo
    Li, Li
    Zhang, Jie
    Huang, Weijia
    Zhao, Yi
    Huang, He
    Zhang, Xuejin
    Fu, Jiaping
    Cai, Zhen
    [J]. BLOOD, 2013, 122 (21)
  • [4] The Choice of Regimens Based on Bortezomib for Patients with Newly Diagnosed Multiple Myeloma
    He, Jingsong
    Yang, Li
    Han, Xiaoyan
    Zheng, Gaofeng
    Zheng, Weiyan
    Wei, Guoqing
    Wu, Wenjun
    Ye, Xiujin
    Shi, Jimin
    Xie, Wanzhuo
    Li, Li
    Zhang, Jie
    Huang, Weijia
    Zhao, Yi
    Huang, He
    Zhang, Xuejin
    Fu, Jiaping
    Cai, Zhen
    [J]. PLOS ONE, 2014, 9 (06):
  • [5] Bortezomib in newly diagnosed multiple myeloma
    James R. Berenson
    [J]. Nature Reviews Clinical Oncology, 2009, 6 : 255 - 256
  • [6] Bortezomib in newly diagnosed multiple myeloma
    Berenson, James R.
    [J]. NATURE REVIEWS CLINICAL ONCOLOGY, 2009, 6 (05) : 255 - 256
  • [7] A Cost-Benefit Analysis of Bortezomib, Lenalidomide, and Bortezomib/Lenalidomide Combination Therapy for Newly Diagnosed Multiple Myeloma
    Fiala, Mark A.
    Wildes, Tanya M.
    Shah, Gunjan L.
    Ghobadi, Armin
    Schroeder, Mark A.
    Stockerl-Goldstein, Keith E.
    Vij, Ravi
    [J]. BLOOD, 2017, 130
  • [8] Bortezomib and Dexamethasone Therapy for Newly Diagnosed Patients With Multiple Myeloma Complicated by Renal Impairment
    Li, Jian
    Zhou, Dao-Bin
    Jiao, Li
    Duan, Ming Hui
    Zhang, Wei
    Zhao, Yong Qiang
    Shen, Ti
    [J]. CLINICAL LYMPHOMA & MYELOMA, 2009, 9 (05): : 394 - 398
  • [9] Bendamustine and prednisone in combination with bortezomib (BPV) in the treatment of patients with newly diagnosed/untreated multiple myeloma
    Poenisch, Wolfram
    Holzvogt, Bruno
    Ploetze, Madlen
    Andrea, Marc
    Bourgeois, Malvina
    Heyn, Simone
    Zehrfeld, Thomas
    Hammerschmidt, Doreen
    Schwarz, Maik
    Edelmann, Thomas
    Becker, Cornelia
    Hoffmann, Franz Albert
    Schwarzer, Andreas
    Kreibich, Ute
    Gutsche, Kerstin
    Reifenrath, Kolja
    Winkelmann, Cornelia
    Krahl, Rainer
    Remane, Yvonne
    Hennig, Evelin
    Schliwa, Thomas
    Lindner, Tom
    Kaiser, Thorsten
    Vucinic, Vladan
    Behre, Gerhard
    Niederwieser, Dietger
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2014, 140 (11) : 1947 - 1956
  • [10] Bendamustine and Prednisone in combination with Bortezomib (BPV) in the treatment of patients with newly diagnosed/untreated multiple myeloma
    Poenisch, W.
    Holzvogt, B.
    Ploetze, M.
    Andrea, M.
    Bourgeois, M.
    Heyn, S.
    Zehrfeld, T.
    Hammerschmidt, D.
    Schwarz, M.
    Edelmann, T.
    Becker, C.
    Hoffmann, F-A
    Schwarzer, A.
    Kreibich, U.
    Gutsche, K.
    Reifenrath, K.
    Winkelmann, C.
    Krahl, R.
    Remane, Y.
    Hennig, E.
    Lindner, T.
    Kaiser, T.
    Vucinic, V.
    Behre, G.
    Niederwieser, D.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 152 - 152
12345